Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Mangiacapra

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Biomarkers in Medicine|June 17, 2010
Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularizationFabio Mangiacapra, Emanuele Barbato
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Letter to the Editor: "The prognostic role of cardiac biomarkers in periprocedural myocardial infarction following coronary artery bypass grafting"Luca Paolucci, Fabio Mangiacapra
Cardiovascular Diagnosis and Therapy|December 1, 2018
Choosing the optimal antiplatelet therapy in atherosclerotic diseaseFabio Mangiacapra, Emanuele Barbato
International Journal of Cardiology|April 27, 2020
Microvascular impairment associated with percutaneous coronary revascularization: The quest for protective microcirculatory strategiesFabio Mangiacapra, Emanuele Barbato
Journal of Cardiovascular Translational Research|December 29, 2012
Clinical implications of platelet-vessel interactionFabio Mangiacapra, Emanuele Barbato
Circulation. Cardiovascular Interventions|October 17, 2013
Letter by Mangiacapra and Barbato regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease"Fabio Mangiacapra, Emanuele Barbato
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 15, 2011
From SYNTAX to FAME, a paradigm shift in revascularization strategies: the key role of fractional flow reserve in guiding myocardial revascularizationFabio Mangiacapra, Emanuele Barbato
International Journal of Cardiology|June 20, 2021
To treat or not to treat intermediate coronary lesions: Are we asking the question wrong?Fabio Mangiacapra, Aaron J Peace
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 23, 2018
P2Y12 inhibition in STEMI: early, strong or both?Fabio Mangiacapra, Germano Di Sciascio
Journal of the American College of Cardiology|June 12, 2012
Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?Germano Di Sciascio, Fabio Mangiacapra
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Biomarkers in Medicine|June 17, 2010
Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularizationFabio Mangiacapra, Emanuele Barbato
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Letter to the Editor: "The prognostic role of cardiac biomarkers in periprocedural myocardial infarction following coronary artery bypass grafting"Luca Paolucci, Fabio Mangiacapra
Cardiovascular Diagnosis and Therapy|December 1, 2018
Choosing the optimal antiplatelet therapy in atherosclerotic diseaseFabio Mangiacapra, Emanuele Barbato
International Journal of Cardiology|April 27, 2020
Microvascular impairment associated with percutaneous coronary revascularization: The quest for protective microcirculatory strategiesFabio Mangiacapra, Emanuele Barbato
Journal of Cardiovascular Translational Research|December 29, 2012
Clinical implications of platelet-vessel interactionFabio Mangiacapra, Emanuele Barbato
Circulation. Cardiovascular Interventions|October 17, 2013
Letter by Mangiacapra and Barbato regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease"Fabio Mangiacapra, Emanuele Barbato
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 15, 2011
From SYNTAX to FAME, a paradigm shift in revascularization strategies: the key role of fractional flow reserve in guiding myocardial revascularizationFabio Mangiacapra, Emanuele Barbato
International Journal of Cardiology|June 20, 2021
To treat or not to treat intermediate coronary lesions: Are we asking the question wrong?Fabio Mangiacapra, Aaron J Peace
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 23, 2018
P2Y12 inhibition in STEMI: early, strong or both?Fabio Mangiacapra, Germano Di Sciascio
Journal of the American College of Cardiology|June 12, 2012
Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?Germano Di Sciascio, Fabio Mangiacapra
Pageof 14